{"transactions":[{"id":312256,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:10:48.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":885,"price":115.58,"value":102288.3,"ownership":{"direct":true},"balance_after":146377,"source":{"system":"sec-edgar","filing":"0001620564-26-000007","document":"form4-03042026_010342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000007/form4-03042026_010342.xml","form_type":"4"}},{"id":312255,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:10:48.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":6615,"price":116.26,"value":769059.9,"ownership":{"direct":true},"balance_after":147262,"source":{"system":"sec-edgar","filing":"0001620564-26-000007","document":"form4-03042026_010342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000007/form4-03042026_010342.xml","form_type":"4"}},{"id":312712,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-27T00:02:35.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":89226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,742 on February 24, 2027, 29,742 on February 24, 2028, and 29,742\n  on February 24, 2029."}],"balance_after":89226,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":89226},"source":{"system":"sec-edgar","filing":"0001620564-26-000002","document":"form4-02272026_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000002/form4-02272026_120229.xml","form_type":"4"}},{"id":312711,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-27T00:02:35.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":21644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":153877,"source":{"system":"sec-edgar","filing":"0001620564-26-000002","document":"form4-02272026_120229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000002/form4-02272026_120229.xml","form_type":"4"}},{"id":316226,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-12-12T22:04:36.000Z","date":"2025-12-11","kind":"gift","planned":false,"acquired":false,"shares":1536,"price":123.28,"value":189358.08,"ownership":{"direct":true},"balance_after":132233,"source":{"system":"sec-edgar","filing":"0001620564-25-000009","document":"form4-12122025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056425000009/form4-12122025_101232.xml","form_type":"4"}},{"id":324612,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-05T00:54:18.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":8462,"price":135.87,"value":1149731.94,"ownership":{"direct":true},"balance_after":133769,"source":{"system":"sec-edgar","filing":"0001415889-25-006789","document":"form4-03052025_120314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925006789/form4-03052025_120314.xml","form_type":"4"}},{"id":325039,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-02-27T23:47:50.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":61580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,526 on February 25, 2026, 20,527 on February 25, 2027, and 20,527 on February 25, 2028."}],"balance_after":61580,"derivative":{"exercise_price":135.42,"exercise_date":"2026-02-25","expiration_date":"2035-02-24","underlying":"Common Shares","underlying_shares":61580},"source":{"system":"sec-edgar","filing":"0001415889-25-005918","document":"form4-02272025_110246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005918/form4-02272025_110246.xml","form_type":"4"}},{"id":325038,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-02-27T23:47:50.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":16534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":142231,"source":{"system":"sec-edgar","filing":"0001415889-25-005918","document":"form4-02272025_110246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005918/form4-02272025_110246.xml","form_type":"4"}},{"id":326810,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-02-01T00:08:40.000Z","date":"2025-01-30","kind":"exercise","planned":false,"acquired":false,"shares":23771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":38.4,"exercise_date":"2019-02-19","expiration_date":"2026-02-18","underlying":"Common Shares","underlying_shares":23771},"source":{"system":"sec-edgar","filing":"0001415889-25-002584","document":"form4-02012025_120236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925002584/form4-02012025_120236.xml","form_type":"4"}},{"id":326809,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-02-01T00:08:40.000Z","date":"2025-01-30","kind":"sale","planned":false,"acquired":false,"shares":23771,"price":128.5,"value":3054573.5,"ownership":{"direct":true},"balance_after":125697,"source":{"system":"sec-edgar","filing":"0001415889-25-002584","document":"form4-02012025_120236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925002584/form4-02012025_120236.xml","form_type":"4"}},{"id":326808,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-02-01T00:08:40.000Z","date":"2025-01-30","kind":"exercise","planned":false,"acquired":true,"shares":23771,"price":38.4,"value":912806.4,"ownership":{"direct":true},"balance_after":149468,"source":{"system":"sec-edgar","filing":"0001415889-25-002584","document":"form4-02012025_120236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925002584/form4-02012025_120236.xml","form_type":"4"}},{"id":338499,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-05T00:18:55.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":963,"price":118.5,"value":114115.5,"ownership":{"direct":true},"balance_after":125697,"source":{"system":"sec-edgar","filing":"0001415889-24-006417","document":"form4-03052024_120350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006417/form4-03052024_120350.xml","form_type":"4"}},{"id":338498,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-05T00:18:55.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":8874,"price":120.05,"value":1065323.7,"ownership":{"direct":true},"balance_after":126660,"source":{"system":"sec-edgar","filing":"0001415889-24-006417","document":"form4-03052024_120350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006417/form4-03052024_120350.xml","form_type":"4"}},{"id":339288,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2024-02-23T22:43:33.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":58898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,632 on February 21, 2025, 19,633 on February 21, 2026, and 19,633 on February 21, 2027."}],"balance_after":58898,"derivative":{"exercise_price":116.98,"exercise_date":"2025-02-21","expiration_date":"2034-02-20","underlying":"Common Shares","underlying_shares":58898},"source":{"system":"sec-edgar","filing":"0001415889-24-005109","document":"form4-02232024_100201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005109/form4-02232024_100201.xml","form_type":"4"}},{"id":339287,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-02-23T22:43:33.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":15673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":135534,"source":{"system":"sec-edgar","filing":"0001415889-24-005109","document":"form4-02232024_100201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005109/form4-02232024_100201.xml","form_type":"4"}},{"id":351999,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:52:41.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1085,"price":100.7,"value":109259.5,"ownership":{"direct":true},"balance_after":119861,"source":{"system":"sec-edgar","filing":"0001415889-23-003916","document":"form4-03032023_120315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003916/form4-03032023_120315.xml","form_type":"4"}},{"id":351998,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:52:41.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":9002,"price":99.77,"value":898129.54,"ownership":{"direct":true},"balance_after":120946,"source":{"system":"sec-edgar","filing":"0001415889-23-003916","document":"form4-03032023_120315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003916/form4-03032023_120315.xml","form_type":"4"}},{"id":352741,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-23T00:18:20.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":69803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,267 on February 17, 2024, 23,268 on February 17, 2025, and 23,268 on February 17, 2026."}],"balance_after":69803,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":69803},"source":{"system":"sec-edgar","filing":"0001415889-23-003060","document":"form4-02232023_120209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003060/form4-02232023_120209.xml","form_type":"4"}},{"id":352740,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-23T00:18:20.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":17700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":129948,"source":{"system":"sec-edgar","filing":"0001415889-23-003060","document":"form4-02232023_120209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003060/form4-02232023_120209.xml","form_type":"4"}},{"id":364694,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:58:51.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1550,"price":118.171,"value":183165.05,"ownership":{"direct":true},"balance_after":112248,"source":{"system":"sec-edgar","filing":"0001415889-22-002200","document":"form4-03022022_040330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002200/form4-03022022_040330.xml","form_type":"4"}},{"id":364693,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:58:51.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":10551,"price":122.41,"value":1291547.91,"ownership":{"direct":true},"balance_after":113798,"source":{"system":"sec-edgar","filing":"0001415889-22-002200","document":"form4-03022022_040330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002200/form4-03022022_040330.xml","form_type":"4"}},{"id":365269,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:28:03.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":111474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,158 on February 18, 2023, 37,158 on February 18, 2024, and 37,158 on February 18, 2025."}],"balance_after":111474,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":111474},"source":{"system":"sec-edgar","filing":"0001415889-22-001744","document":"form4-02232022_050251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001744/form4-02232022_050251.xml","form_type":"4"}},{"id":365268,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:28:03.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":23919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":124349,"source":{"system":"sec-edgar","filing":"0001415889-22-001744","document":"form4-02232022_050251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001744/form4-02232022_050251.xml","form_type":"4"}},{"id":368142,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-12-28T22:20:56.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":31229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":75591,"derivative":{"exercise_price":44.4,"exercise_date":"2019-02-17","expiration_date":"2027-02-16","underlying":"Common Shares","underlying_shares":31229},"source":{"system":"sec-edgar","filing":"0001415889-21-006263","document":"form4-12282021_021241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921006263/form4-12282021_021241.xml","form_type":"4"}},{"id":368141,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-12-28T22:20:56.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":23771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":23771,"derivative":{"exercise_price":38.4,"exercise_date":"2018-02-19","expiration_date":"2026-02-18","underlying":"Common Shares","underlying_shares":23771},"source":{"system":"sec-edgar","filing":"0001415889-21-006263","document":"form4-12282021_021241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921006263/form4-12282021_021241.xml","form_type":"4"}},{"id":368140,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-28T22:20:56.000Z","date":"2021-12-23","kind":"sale","acquired":false,"shares":58501,"price":140,"value":8190140.0,"ownership":{"direct":true},"balance_after":100430,"source":{"system":"sec-edgar","filing":"0001415889-21-006263","document":"form4-12282021_021241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921006263/form4-12282021_021241.xml","form_type":"4"}},{"id":368139,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-28T22:20:56.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":31229,"price":44.4,"value":1386567.6,"ownership":{"direct":true},"balance_after":158931,"source":{"system":"sec-edgar","filing":"0001415889-21-006263","document":"form4-12282021_021241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921006263/form4-12282021_021241.xml","form_type":"4"}},{"id":368138,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-28T22:20:56.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":23771,"price":38.4,"value":912806.4,"ownership":{"direct":true},"balance_after":127702,"source":{"system":"sec-edgar","filing":"0001415889-21-006263","document":"form4-12282021_021241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921006263/form4-12282021_021241.xml","form_type":"4"}},{"id":368587,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-12-15T23:34:26.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":31229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":60803,"derivative":{"exercise_price":44.4,"exercise_date":"2020-02-17","expiration_date":"2027-02-16","underlying":"Common Shares","underlying_shares":31229},"source":{"system":"sec-edgar","filing":"0001415889-21-005967","document":"form4-12152021_031216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005967/form4-12152021_031216.xml","form_type":"4"}},{"id":368586,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-12-15T23:34:26.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":23771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":47542,"derivative":{"exercise_price":38.4,"exercise_date":"2019-02-19","expiration_date":"2026-02-18","underlying":"Common Shares","underlying_shares":23771},"source":{"system":"sec-edgar","filing":"0001415889-21-005967","document":"form4-12152021_031216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005967/form4-12152021_031216.xml","form_type":"4"}},{"id":368585,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-15T23:34:26.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":55000,"price":135,"value":7425000.0,"ownership":{"direct":true},"balance_after":103931,"source":{"system":"sec-edgar","filing":"0001415889-21-005967","document":"form4-12152021_031216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005967/form4-12152021_031216.xml","form_type":"4"}},{"id":368584,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-15T23:34:26.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":31229,"price":44.4,"value":1386567.6,"ownership":{"direct":true},"balance_after":158931,"source":{"system":"sec-edgar","filing":"0001415889-21-005967","document":"form4-12152021_031216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005967/form4-12152021_031216.xml","form_type":"4"}},{"id":368583,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-15T23:34:26.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":23771,"price":38.4,"value":912806.4,"ownership":{"direct":true},"balance_after":127702,"source":{"system":"sec-edgar","filing":"0001415889-21-005967","document":"form4-12152021_031216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005967/form4-12152021_031216.xml","form_type":"4"}},{"id":368582,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-15T23:34:26.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":3499,"price":135,"value":472365.0,"ownership":{"direct":true},"balance_after":103931,"source":{"system":"sec-edgar","filing":"0001415889-21-005967","document":"form4-12152021_031216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005967/form4-12152021_031216.xml","form_type":"4"}},{"id":379011,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:54:14.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1664,"price":120.61,"value":200695.04,"ownership":{"direct":true},"balance_after":107430,"source":{"system":"sec-edgar","filing":"0001415889-21-001212","document":"form4-03022021_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001212/form4-03022021_040302.xml","form_type":"4"}},{"id":379010,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:54:14.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":12596,"price":121.58,"value":1531421.68,"ownership":{"direct":true},"balance_after":109094,"source":{"system":"sec-edgar","filing":"0001415889-21-001212","document":"form4-03022021_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001212/form4-03022021_040302.xml","form_type":"4"}},{"id":379650,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-24T00:10:24.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":98708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,902 on February 19, 2022, 32,903 on February 19, 2023, and 32,903 on February 19, 2024."}],"balance_after":98708,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":98708},"source":{"system":"sec-edgar","filing":"0001415889-21-000899","document":"form4-02232021_040224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000899/form4-02232021_040224.xml","form_type":"4"}},{"id":379649,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-24T00:10:24.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":19257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":121690,"source":{"system":"sec-edgar","filing":"0001415889-21-000899","document":"form4-02232021_040224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000899/form4-02232021_040224.xml","form_type":"4"}},{"id":386718,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2020-08-31T22:28:36.000Z","date":"2020-08-27","kind":"exercise","acquired":false,"shares":42479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":47,"exercise_date":"2018-02-20","expiration_date":"2025-02-19","underlying":"Common shares","underlying_shares":42479},"source":{"system":"sec-edgar","filing":"0001179110-20-009447","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020009447/edgar.xml","form_type":"4"}},{"id":386717,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-08-31T22:28:36.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":42479,"price":111.86,"value":4751700.94,"ownership":{"direct":true},"balance_after":102433,"source":{"system":"sec-edgar","filing":"0001179110-20-009447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020009447/edgar.xml","form_type":"4"}},{"id":386716,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-08-31T22:28:36.000Z","date":"2020-08-27","kind":"exercise","acquired":true,"shares":42479,"price":47,"value":1996513.0,"ownership":{"direct":true},"balance_after":144912,"source":{"system":"sec-edgar","filing":"0001179110-20-009447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020009447/edgar.xml","form_type":"4"}},{"id":388063,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-07-23T21:05:28.000Z","date":"2020-07-21","kind":"tax_withholding","acquired":false,"shares":1060,"price":99.08,"value":105024.8,"ownership":{"direct":true},"balance_after":102433,"source":{"system":"sec-edgar","filing":"0001179110-20-008463","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020008463/edgar.xml","form_type":"4"}},{"id":393959,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:16:01.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":999,"price":77.89,"value":77812.11,"ownership":{"direct":true},"balance_after":103493,"source":{"system":"sec-edgar","filing":"0001179110-20-002895","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002895/edgar.xml","form_type":"4"}},{"id":393958,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:16:01.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":12279,"price":79.19,"value":972374.01,"ownership":{"direct":true},"balance_after":104492,"source":{"system":"sec-edgar","filing":"0001179110-20-002895","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002895/edgar.xml","form_type":"4"}},{"id":394480,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Options (right to buy)","published_at":"2020-02-25T22:32:38.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":132182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,060 on February 21, 2021, 44,061 on February 21, 2022, and 44,061 on February 21, 2023."}],"balance_after":132182,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":132182},"source":{"system":"sec-edgar","filing":"0001179110-20-002286","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002286/edgar.xml","form_type":"4"}},{"id":394479,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:32:38.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":21683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":116771,"source":{"system":"sec-edgar","filing":"0001179110-20-002286","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002286/edgar.xml","form_type":"4"}},{"id":401350,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-07-23T22:34:21.000Z","date":"2019-07-21","kind":"tax_withholding","acquired":false,"shares":1060,"price":87.49,"value":92739.4,"ownership":{"direct":true},"balance_after":95088,"source":{"system":"sec-edgar","filing":"0001179110-19-008773","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008773/edgar.xml","form_type":"4"}},{"id":401859,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2019-06-27T21:01:45.000Z","date":"2019-06-26","kind":"exercise","acquired":false,"shares":71000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":71313,"derivative":{"exercise_price":38.4,"exercise_date":"2018-02-19","expiration_date":"2026-02-18","underlying":"Common shares","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001179110-19-008174","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008174/edgar.xml","form_type":"4"}},{"id":401858,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-27T21:01:45.000Z","date":"2019-06-26","kind":"sale","acquired":false,"shares":71000,"price":84.0001,"value":5964007.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":96148,"source":{"system":"sec-edgar","filing":"0001179110-19-008174","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008174/edgar.xml","form_type":"4"}},{"id":401857,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-27T21:01:45.000Z","date":"2019-06-26","kind":"exercise","acquired":true,"shares":71000,"price":38.4,"value":2726400.0,"ownership":{"direct":true},"balance_after":167148,"source":{"system":"sec-edgar","filing":"0001179110-19-008174","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008174/edgar.xml","form_type":"4"}},{"id":402230,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-13T21:12:24.000Z","date":"2019-06-13","kind":"sale","acquired":false,"shares":3331,"price":82,"value":273142.0,"ownership":{"direct":true},"balance_after":96148,"source":{"system":"sec-edgar","filing":"0001179110-19-007613","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019007613/edgar.xml","form_type":"4"}},{"id":402229,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-13T21:12:24.000Z","date":"2019-06-11","kind":"sale","acquired":false,"shares":7269,"price":82,"value":596058.0,"ownership":{"direct":true},"balance_after":99479,"source":{"system":"sec-edgar","filing":"0001179110-19-007613","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019007613/edgar.xml","form_type":"4"}},{"id":406298,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:32:17.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":1664,"price":78,"value":129792.0,"ownership":{"direct":true},"balance_after":106748,"source":{"system":"sec-edgar","filing":"0001179110-19-003124","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003124/edgar.xml","form_type":"4"}},{"id":406297,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:32:17.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":11097,"price":77.23,"value":857021.31,"ownership":{"direct":true},"balance_after":108412,"source":{"system":"sec-edgar","filing":"0001179110-19-003124","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003124/edgar.xml","form_type":"4"}},{"id":406858,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2019-02-26T22:12:04.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":162430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 54,143 on February 22, 2020, 54,143 on February 22, 2021, and 54,144 on February 22, 2022."}],"balance_after":162430,"derivative":{"exercise_price":75.9,"exercise_date":"2020-02-22","expiration_date":"2029-02-21","underlying":"Common shares","underlying_shares":162430},"source":{"system":"sec-edgar","filing":"0001179110-19-002647","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002647/edgar.xml","form_type":"4"}},{"id":406857,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-02-26T22:12:04.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":30988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":119509,"source":{"system":"sec-edgar","filing":"0001179110-19-002647","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002647/edgar.xml","form_type":"4"}},{"id":411582,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-10-02T22:58:12.000Z","date":"2018-09-28","kind":"sale","acquired":false,"shares":4800,"price":73.391,"value":352276.8,"ownership":{"direct":true},"balance_after":88521,"source":{"system":"sec-edgar","filing":"0001179110-18-011958","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018011958/edgar.xml","form_type":"4"}},{"id":411581,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-10-02T22:58:12.000Z","date":"2018-09-28","kind":"sale","acquired":false,"shares":200,"price":73.401,"value":14680.2,"ownership":{"direct":true},"balance_after":93321,"source":{"system":"sec-edgar","filing":"0001179110-18-011958","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018011958/edgar.xml","form_type":"4"}},{"id":413368,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-07-24T21:02:58.000Z","date":"2018-07-21","kind":"tax_withholding","acquired":false,"shares":1060,"price":63.32,"value":67119.2,"ownership":{"direct":true},"balance_after":93521,"source":{"system":"sec-edgar","filing":"0001179110-18-009887","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018009887/edgar.xml","form_type":"4"}},{"id":414814,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-05-21T21:16:34.000Z","date":"2018-05-18","kind":"sale","acquired":false,"shares":1000,"price":61.5,"value":61500.0,"ownership":{"direct":true},"balance_after":94581,"source":{"system":"sec-edgar","filing":"0001179110-18-007253","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018007253/edgar.xml","form_type":"4"}},{"id":414813,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-05-21T21:16:34.000Z","date":"2018-05-17","kind":"sale","acquired":false,"shares":2000,"price":61.046,"value":122092.0,"ownership":{"direct":true},"balance_after":95581,"source":{"system":"sec-edgar","filing":"0001179110-18-007253","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018007253/edgar.xml","form_type":"4"}},{"id":417542,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-03-02T22:15:16.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":905,"price":58.971,"value":53368.755,"ownership":{"direct":true},"balance_after":97581,"source":{"system":"sec-edgar","filing":"0001179110-18-003314","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003314/edgar.xml","form_type":"4"}},{"id":417541,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-03-02T22:15:16.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":8578,"price":60.55,"value":519397.9,"ownership":{"direct":true},"balance_after":98486,"source":{"system":"sec-edgar","filing":"0001179110-18-003314","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003314/edgar.xml","form_type":"4"}},{"id":418551,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2018-02-21T23:23:06.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":182935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 60,979 on 02/16/2019, 60,978 on 2/16/2020, and 60,978 on 02/16/2021."}],"balance_after":182935,"derivative":{"exercise_price":59.94,"exercise_date":"2019-02-16","expiration_date":"2028-02-15","underlying":"Common shares","underlying_shares":182935},"source":{"system":"sec-edgar","filing":"0001179110-18-002518","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002518/edgar.xml","form_type":"4"}},{"id":418550,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-02-21T23:23:06.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":33266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":107064,"source":{"system":"sec-edgar","filing":"0001179110-18-002518","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002518/edgar.xml","form_type":"4"}},{"id":421287,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"exercise","acquired":false,"shares":28319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":42479,"derivative":{"exercise_price":47,"exercise_date":"2017-02-20","expiration_date":"2025-02-19","underlying":"Common shares","underlying_shares":28319},"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421286,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":7700,"price":54.935,"value":422999.5,"ownership":{"direct":true},"balance_after":73798,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421285,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":6897,"price":54.93,"value":378852.21,"ownership":{"direct":true},"balance_after":81498,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421284,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":100,"price":54.9214,"value":5492.14,"ownership":{"direct":true},"balance_after":88395,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421283,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":1900,"price":54.92,"value":104348.0,"ownership":{"direct":true},"balance_after":88495,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421282,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":200,"price":54.915,"value":10983.0,"ownership":{"direct":true},"balance_after":90395,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421281,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":200,"price":54.911,"value":10982.2,"ownership":{"direct":true},"balance_after":90595,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421280,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":1483,"price":54.91,"value":81431.53,"ownership":{"direct":true},"balance_after":90795,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421279,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":9839,"price":54.901,"value":540170.939,"ownership":{"direct":true},"balance_after":92278,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":421278,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-12-14T23:01:01.000Z","date":"2017-12-14","kind":"exercise","acquired":true,"shares":28319,"price":47,"value":1330993.0,"ownership":{"direct":true},"balance_after":102117,"source":{"system":"sec-edgar","filing":"0001179110-17-015385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017015385/edgar.xml","form_type":"4"}},{"id":422170,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-11-16T22:06:59.000Z","date":"2017-11-14","kind":"exercise","acquired":false,"shares":71157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":142313,"derivative":{"exercise_price":38.4,"exercise_date":"2017-02-19","expiration_date":"2026-02-18","underlying":"Common shares","underlying_shares":71157},"source":{"system":"sec-edgar","filing":"0001179110-17-014210","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017014210/edgar.xml","form_type":"4"}},{"id":422169,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-11-16T22:06:59.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":71157,"price":55,"value":3913635.0,"ownership":{"direct":true},"balance_after":73798,"source":{"system":"sec-edgar","filing":"0001179110-17-014210","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017014210/edgar.xml","form_type":"4"}},{"id":422168,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-11-16T22:06:59.000Z","date":"2017-11-14","kind":"exercise","acquired":true,"shares":71157,"price":38.4,"value":2732428.8,"ownership":{"direct":true},"balance_after":144955,"source":{"system":"sec-edgar","filing":"0001179110-17-014210","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017014210/edgar.xml","form_type":"4"}},{"id":422785,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-10-25T21:03:41.000Z","date":"2017-10-23","kind":"exercise","acquired":false,"shares":28319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":70798,"derivative":{"exercise_price":47,"exercise_date":"2016-02-20","expiration_date":"2025-02-19","underlying":"Common shares","underlying_shares":28319},"source":{"system":"sec-edgar","filing":"0001179110-17-013439","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017013439/edgar.xml","form_type":"4"}},{"id":422784,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-10-25T21:03:41.000Z","date":"2017-10-23","kind":"exercise","acquired":false,"shares":34142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":42.08,"exercise_date":"2017-09-26","expiration_date":"2024-09-25","underlying":"Common shares","underlying_shares":34142},"source":{"system":"sec-edgar","filing":"0001179110-17-013439","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017013439/edgar.xml","form_type":"4"}},{"id":422783,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-10-25T21:03:41.000Z","date":"2017-10-23","kind":"exercise","acquired":false,"shares":34142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":34142,"derivative":{"exercise_price":42.08,"exercise_date":"2016-09-26","expiration_date":"2024-09-25","underlying":"Common shares","underlying_shares":34142},"source":{"system":"sec-edgar","filing":"0001179110-17-013439","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017013439/edgar.xml","form_type":"4"}},{"id":422782,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-10-25T21:03:41.000Z","date":"2017-10-23","kind":"sale","acquired":false,"shares":96603,"price":56.21,"value":5430054.63,"ownership":{"direct":true},"balance_after":73798,"source":{"system":"sec-edgar","filing":"0001179110-17-013439","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017013439/edgar.xml","form_type":"4"}},{"id":422781,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-10-25T21:03:41.000Z","date":"2017-10-23","kind":"exercise","acquired":true,"shares":28319,"price":47,"value":1330993.0,"ownership":{"direct":true},"balance_after":170401,"source":{"system":"sec-edgar","filing":"0001179110-17-013439","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017013439/edgar.xml","form_type":"4"}},{"id":422780,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-10-25T21:03:41.000Z","date":"2017-10-23","kind":"exercise","acquired":true,"shares":68284,"price":42.08,"value":2873390.72,"ownership":{"direct":true},"balance_after":142082,"source":{"system":"sec-edgar","filing":"0001179110-17-013439","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017013439/edgar.xml","form_type":"4"}},{"id":423278,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-09-28T21:13:34.000Z","date":"2017-09-26","kind":"exercise","acquired":false,"shares":28319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":99117,"derivative":{"exercise_price":47,"exercise_date":"2017-02-20","expiration_date":"2025-02-19","underlying":"Common shares","underlying_shares":28319},"source":{"system":"sec-edgar","filing":"0001179110-17-012749","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012749/edgar.xml","form_type":"4"}},{"id":423277,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-09-28T21:13:34.000Z","date":"2017-09-26","kind":"exercise","acquired":false,"shares":34141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":68284,"derivative":{"exercise_price":42.08,"exercise_date":"2017-09-26","expiration_date":"2024-09-25","underlying":"Common shares","underlying_shares":34141},"source":{"system":"sec-edgar","filing":"0001179110-17-012749","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012749/edgar.xml","form_type":"4"}},{"id":423276,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-09-28T21:13:34.000Z","date":"2017-09-26","kind":"tax_withholding","acquired":false,"shares":5487,"price":52.61,"value":288671.07,"ownership":{"direct":true},"balance_after":73798,"source":{"system":"sec-edgar","filing":"0001179110-17-012749","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012749/edgar.xml","form_type":"4"}},{"id":423275,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-09-28T21:13:34.000Z","date":"2017-09-26","kind":"sale","acquired":false,"shares":62460,"price":52.95,"value":3307257.0,"ownership":{"direct":true},"balance_after":79285,"source":{"system":"sec-edgar","filing":"0001179110-17-012749","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012749/edgar.xml","form_type":"4"}},{"id":423274,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-09-28T21:13:34.000Z","date":"2017-09-26","kind":"exercise","acquired":true,"shares":28319,"price":47,"value":1330993.0,"ownership":{"direct":true},"balance_after":141745,"source":{"system":"sec-edgar","filing":"0001179110-17-012749","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012749/edgar.xml","form_type":"4"}},{"id":423273,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-09-28T21:13:34.000Z","date":"2017-09-26","kind":"exercise","acquired":true,"shares":34141,"price":42.08,"value":1436653.28,"ownership":{"direct":true},"balance_after":113426,"source":{"system":"sec-edgar","filing":"0001179110-17-012749","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012749/edgar.xml","form_type":"4"}},{"id":424572,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-07-25T21:37:20.000Z","date":"2017-07-21","kind":"grant","acquired":true,"shares":49611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,537 on 07/21/2018, 16,537 on 07/21/2019, and 16,537 on 07/21/2020."}],"balance_after":49611,"derivative":{"exercise_price":50.72,"exercise_date":"2018-07-21","expiration_date":"2027-07-20","underlying":"Common shares","underlying_shares":49611},"source":{"system":"sec-edgar","filing":"0001179110-17-010659","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010659/edgar.xml","form_type":"4"}},{"id":424571,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-07-25T21:37:20.000Z","date":"2017-07-21","kind":"grant","acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":79285,"source":{"system":"sec-edgar","filing":"0001179110-17-010659","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010659/edgar.xml","form_type":"4"}},{"id":429019,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-03-02T22:16:34.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":2066,"price":45.39,"value":93775.74,"ownership":{"direct":true},"balance_after":72112,"source":{"system":"sec-edgar","filing":"0001179110-17-003680","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017003680/edgar.xml","form_type":"4"}},{"id":429018,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-03-02T22:16:34.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":4759,"price":45.46,"value":216344.14,"ownership":{"direct":true},"balance_after":74178,"source":{"system":"sec-edgar","filing":"0001179110-17-003680","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017003680/edgar.xml","form_type":"4"}},{"id":429708,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-02-22T23:11:25.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":138049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 46,017 on 2/17/2018, 46,016 on 2/17/2019, and 46,016 on 2/17/2020."}],"balance_after":138049,"derivative":{"exercise_price":44.4,"exercise_date":"2018-02-17","expiration_date":"2027-02-16","underlying":"Common shares","underlying_shares":138049},"source":{"system":"sec-edgar","filing":"0001179110-17-002968","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002968/edgar.xml","form_type":"4"}},{"id":429707,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-02-22T23:11:25.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":19961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":78937,"source":{"system":"sec-edgar","filing":"0001179110-17-002968","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002968/edgar.xml","form_type":"4"}},{"id":434840,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2016-09-28T21:05:10.000Z","date":"2016-09-26","kind":"sale","acquired":false,"shares":815,"price":41.711,"value":33994.465,"ownership":{"direct":true},"balance_after":58976,"source":{"system":"sec-edgar","filing":"0001179110-16-030075","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016030075/edgar.xml","form_type":"4"}},{"id":434839,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2016-09-28T21:05:10.000Z","date":"2016-09-26","kind":"tax_withholding","acquired":false,"shares":2001,"price":42.19,"value":84422.19,"ownership":{"direct":true},"balance_after":59791,"source":{"system":"sec-edgar","filing":"0001179110-16-030075","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016030075/edgar.xml","form_type":"4"}},{"id":441025,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2016-03-03T00:02:27.000Z","date":"2016-02-29","kind":"sale","acquired":false,"shares":100,"price":39.265,"value":3926.5,"ownership":{"direct":true},"balance_after":61792,"source":{"system":"sec-edgar","filing":"0001179110-16-020732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016020732/edgar.xml","form_type":"4"}},{"id":441024,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2016-03-03T00:02:27.000Z","date":"2016-02-29","kind":"sale","acquired":false,"shares":81,"price":39.262,"value":3180.222,"ownership":{"direct":true},"balance_after":61892,"source":{"system":"sec-edgar","filing":"0001179110-16-020732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016020732/edgar.xml","form_type":"4"}}],"next_cursor":"2016-03-03T00:02:27.000000Z,441024"}